BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26658573)

  • 21. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
    Wagener G; Raffel B; Young AT; Minhaz M; Emond J
    Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of early allograft dysfunction using serum phosphorus level in living donor liver transplantation.
    Hong SH; Kwak JA; Chon JY; Park CS
    Transpl Int; 2013 Apr; 26(4):402-10. PubMed ID: 23350888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
    Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
    Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid increase of interleukin-10 plasma levels after combined auxiliary liver-kidney transplantation in presensitized patients.
    Ingelsten M; Gustafsson K; Olausson M; Haraldsson B; Karlsson-Parra A; Nyström J
    Transplantation; 2014 Jul; 98(2):208-15. PubMed ID: 24598935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function.
    Matz M; Beyer J; Wunsch D; Mashreghi MF; Seiler M; Pratschke J; Babel N; Volk HD; Reinke P; Kotsch K
    Kidney Int; 2006 May; 69(9):1683-90. PubMed ID: 16572110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Sebastiani M; Fallahi P
    J Rheumatol; 2010 Jan; 37(1):91-7. PubMed ID: 19918044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive utility of the C-reactive protein to albumin ratio in early allograft dysfunction in living donor liver transplantation: A retrospective observational cohort study.
    Park J; Lim SJ; Choi HJ; Hong SH; Park CS; Choi JH; Chae MS
    PLoS One; 2019; 14(12):e0226369. PubMed ID: 31821367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.
    Olthoff KM; Kulik L; Samstein B; Kaminski M; Abecassis M; Emond J; Shaked A; Christie JD
    Liver Transpl; 2010 Aug; 16(8):943-9. PubMed ID: 20677285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
    Starling AL; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Pascoal-Xavier MA; Gonçalves DU; Béla SR; Lambertucci JR; Labanca L; Souza Pereira SR; Teixeira-Carvalho A; Ribas JG; Trindade BC; Faccioli LH; Carneiro-Proietti AB; Martins-Filho OA
    Biomarkers; 2015; 20(6-7):502-12. PubMed ID: 26474234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low serum factor V level: early predictor of allograft failure and death following liver transplantation.
    Zulian MC; Chedid MF; Chedid AD; Grezzana Filho TJ; Leipnitz I; de Araujo A; Alvares-da-Silva MR; Cardoni MG; Guimaraes LS; Kruel CD; Kruel CR
    Langenbecks Arch Surg; 2015 Jul; 400(5):589-97. PubMed ID: 25708642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
    Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
    J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection.
    Kim KH; Oh EJ; Jung ES; Park YJ; Choi JY; Kim DG; Lee KY; Kang CS
    Transplant Proc; 2006 Jun; 38(5):1429-31. PubMed ID: 16797323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of therapeutic plasma exchange on early allograft dysfunction after liver transplantation.
    Choe W; Kwon SW; Kim SS; Hwang S; Song GW; Lee SG
    J Clin Apher; 2017 Jun; 32(3):147-153. PubMed ID: 27306278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of immunological biomarkers in cardiac rejection.
    Crescioli C
    Curr Opin Organ Transplant; 2013 Oct; 18(5):595-600. PubMed ID: 23995367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of urinary interferon-gamma inducible protein-10 (IP10/CXCL10) levels with kidney allograft rejection.
    Raza A; Firasat S; Khaliq S; Aziz T; Mubarak M; Naqvi SA; Mehdi SQ; Rizvi SA; Abid A
    Inflamm Res; 2017 May; 66(5):425-432. PubMed ID: 28246678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.
    Salvalaggio PR; Felga GE; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2449-51. PubMed ID: 23026617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated proteomics and metabolomics approach to assess graft quality and predict early allograft dysfunction after liver transplantation: a retrospective cohort study.
    Lin Y; Huang H; Cao J; Zhang K; Chen R; Jiang J; Yi X; Feng S; Liu J; Zheng S; Ling Q
    Int J Surg; 2024 Jun; 110(6):3480-3494. PubMed ID: 38502860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory markers sampled by microdialysis catheters distinguish rejection from ischemia in liver grafts.
    Haugaa H; Thorgersen EB; Pharo A; Boberg KM; Foss A; Line PD; Sanengen T; Almaas R; Grindheim G; Waelgaard L; Pischke SE; Mollnes TE; Inge Tønnessen T
    Liver Transpl; 2012 Dec; 18(12):1421-9. PubMed ID: 22767413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients.
    Gras J; Wieërs G; Vaerman JL; Truong DQ; Sokal E; Otte JB; Délépaut B; Cornet A; de Ville de Goyet J; Latinne D; Reding R
    Liver Transpl; 2007 Mar; 13(3):426-33. PubMed ID: 17318867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.